Design and Analysis of Analytical Method Transfer Studies

REFERENCES

• Crawford , L. M. , U.S. Food and Drug Administration . ( 2002 ). Pharmaceutical cGMPs Initiative . Food and Drug Administration (FDA) announcement . Washington , DC : FDA . www.fda.gov/oc/guidance/announce.html .
   Google Scholar
• Food and Drug Administration, Center for Drug Evaluation and Research . ( 2004a ). Pharmaceutical GMPs for the 21st Century—A Risked Based Approach, Final Report . Washington , DC : FDA . www.fda.gov/cder/gmp/gmp2004/GMP_finalreport2004.htm .
   Google Scholar
• Food and Drug Administration, Center for Drug Evaluation and Research . ( 2004b ). PAT—A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance . Washington , DC : FDA . www.fda.gov/cder/guidance/6419fnl.pdf .
   Google Scholar
• Food and Drug Administration, Center for Drug Evaluation and Research . ( 2006 ). Quality Systems Approach to Pharmaceutical cGMP Regulations . Washington , DC : FDA . www.fda.gov/cder/guidance/7260fnl.pdf .
   Google Scholar
• International Conference on Harmonization Guideline (ICH) . ( 2005a ). Q8 (step 4), Pharmaceutical Development . www.ich.org/LOB/media/MEDIA1707.pdf .
   Google Scholar
• International Conference on Harmonization Guideline (ICH) . ( 2005b ). Q9 (step 4), Quality Risk Management . www.ich.org/LOB/media/MEDIA1957.pdf .
   Google Scholar
• ISPE . ( 2003 ). ISPE Good Practice Guide: Technology Transfer . Tampa , FL : ISPE .
   Google Scholar
• Littell , R. C. , Milliken , G. A. , Stroup , W. W. , Wolfinger , R. D. , Schabenberger , O. ( 2006 ). SAS® for Mixed Models, , Second Edition . Cary , NC : SAS Institute Inc .
   Google Scholar
• Milliken , G. A. , Johnson , D. E. ( 1992 ). Analysis of Messy Data, Volume I: Designed Experiments . Boca Raton , FL : Chapman and Hall/CRC .
   Google Scholar
• Pharmaceutical Research and Manufacturers Association Analytical Research and Development Workshop, Wilmington, Delaware ( 2000 ).
   Google Scholar
• Schuirmann , D. J. ( 1987 ). A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability . J. Pharmacokinet Biopharmaceutics 15 : 657 – 680 .
   PubMedGoogle Scholar
• Scypinski , S. , Roberts , D. , Oates , M. , Etse , J. ( 2004 ). Pharmaceutical Research and Manufacturers Association Acceptable Analytical Practice for Analytical Method Transfer . Pharm. Tech. 28 : 84 – 88 .
   Google Scholar
• Tougas , T. ( 2006 ). Considerations of the role of end product testing in assuring the quality of pharmaceutical products . Proc. Anal. Technol. 3 : 13 – 17 .
   Google Scholar